Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors

Hajer Ouertatani-Sakouhi, Min Liu, Farah El-Turk, Gregory D. Cuny, Marcie A. Glicksman, Hilala Lashuel

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Macrophage migration inhibitory factor (MIF) is a major mediator of innate immunity and inflammation and presents a potential therapeutic target for various inflammatory, infectious, and autoimmune diseases, including cancer. Although a number of inhibitors have been identified and designed based on the modification of known nonphysiological substrates, the lack of a suitable high-throughput assay has hindered the screening of chemical libraries and the discovery of more diverse inhibitors. Herein the authors report the development and optimization of a robust high-throughput kinetic-based activity assay for the identification of new MIF inhibitors. Using this assay, they screened 80,000 small molecules and identified and validated 13 novel inhibitors of MIF catalytic activity. These small molecules demonstrated inhibition constant (Ki,app) values ranging from 0.5 to 13 μM.

Original languageEnglish
Pages (from-to)347-358
Number of pages12
JournalJournal of Biomolecular Screening
Volume15
Issue number4
DOIs
Publication statusPublished - 1 Apr 2010
Externally publishedYes

Fingerprint

High-Throughput Screening Assays
Small Molecule Libraries
Macrophage Migration-Inhibitory Factors
Innate Immunity
Autoimmune Diseases
Communicable Diseases
Assays
Screening
Throughput
Inflammation
Kinetics
Neoplasms
Molecules
Application programs
Catalyst activity
Therapeutics
Substrates

Keywords

  • High throughput screening
  • HTS
  • Inflammatory diseases
  • Macrophage migration inhibitory factor
  • MIF
  • Tautomerase activity

ASJC Scopus subject areas

  • Analytical Chemistry
  • Drug Discovery
  • Pharmacology
  • Biochemistry
  • Molecular Medicine
  • Biotechnology

Cite this

Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors. / Ouertatani-Sakouhi, Hajer; Liu, Min; El-Turk, Farah; Cuny, Gregory D.; Glicksman, Marcie A.; Lashuel, Hilala.

In: Journal of Biomolecular Screening, Vol. 15, No. 4, 01.04.2010, p. 347-358.

Research output: Contribution to journalArticle

Ouertatani-Sakouhi, Hajer ; Liu, Min ; El-Turk, Farah ; Cuny, Gregory D. ; Glicksman, Marcie A. ; Lashuel, Hilala. / Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors. In: Journal of Biomolecular Screening. 2010 ; Vol. 15, No. 4. pp. 347-358.
@article{1deb1a30502442a2941fb4880ed510b7,
title = "Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors",
abstract = "Macrophage migration inhibitory factor (MIF) is a major mediator of innate immunity and inflammation and presents a potential therapeutic target for various inflammatory, infectious, and autoimmune diseases, including cancer. Although a number of inhibitors have been identified and designed based on the modification of known nonphysiological substrates, the lack of a suitable high-throughput assay has hindered the screening of chemical libraries and the discovery of more diverse inhibitors. Herein the authors report the development and optimization of a robust high-throughput kinetic-based activity assay for the identification of new MIF inhibitors. Using this assay, they screened 80,000 small molecules and identified and validated 13 novel inhibitors of MIF catalytic activity. These small molecules demonstrated inhibition constant (Ki,app) values ranging from 0.5 to 13 μM.",
keywords = "High throughput screening, HTS, Inflammatory diseases, Macrophage migration inhibitory factor, MIF, Tautomerase activity",
author = "Hajer Ouertatani-Sakouhi and Min Liu and Farah El-Turk and Cuny, {Gregory D.} and Glicksman, {Marcie A.} and Hilala Lashuel",
year = "2010",
month = "4",
day = "1",
doi = "10.1177/1087057110363825",
language = "English",
volume = "15",
pages = "347--358",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors

AU - Ouertatani-Sakouhi, Hajer

AU - Liu, Min

AU - El-Turk, Farah

AU - Cuny, Gregory D.

AU - Glicksman, Marcie A.

AU - Lashuel, Hilala

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Macrophage migration inhibitory factor (MIF) is a major mediator of innate immunity and inflammation and presents a potential therapeutic target for various inflammatory, infectious, and autoimmune diseases, including cancer. Although a number of inhibitors have been identified and designed based on the modification of known nonphysiological substrates, the lack of a suitable high-throughput assay has hindered the screening of chemical libraries and the discovery of more diverse inhibitors. Herein the authors report the development and optimization of a robust high-throughput kinetic-based activity assay for the identification of new MIF inhibitors. Using this assay, they screened 80,000 small molecules and identified and validated 13 novel inhibitors of MIF catalytic activity. These small molecules demonstrated inhibition constant (Ki,app) values ranging from 0.5 to 13 μM.

AB - Macrophage migration inhibitory factor (MIF) is a major mediator of innate immunity and inflammation and presents a potential therapeutic target for various inflammatory, infectious, and autoimmune diseases, including cancer. Although a number of inhibitors have been identified and designed based on the modification of known nonphysiological substrates, the lack of a suitable high-throughput assay has hindered the screening of chemical libraries and the discovery of more diverse inhibitors. Herein the authors report the development and optimization of a robust high-throughput kinetic-based activity assay for the identification of new MIF inhibitors. Using this assay, they screened 80,000 small molecules and identified and validated 13 novel inhibitors of MIF catalytic activity. These small molecules demonstrated inhibition constant (Ki,app) values ranging from 0.5 to 13 μM.

KW - High throughput screening

KW - HTS

KW - Inflammatory diseases

KW - Macrophage migration inhibitory factor

KW - MIF

KW - Tautomerase activity

UR - http://www.scopus.com/inward/record.url?scp=77952384701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952384701&partnerID=8YFLogxK

U2 - 10.1177/1087057110363825

DO - 10.1177/1087057110363825

M3 - Article

VL - 15

SP - 347

EP - 358

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 4

ER -